Ontology highlight
ABSTRACT: Background
Ischemic stroke (IS) is a major contributor to global morbidity and mortality, responsible for over 5 million deaths and 15 million survivors annually, the majority of whom experience long-term disability. The growing burden of IS, driven by aging populations and the increasing prevalence of hypertension, diabetes, and cardiovascular disease, underscores the urgent need for reliable prognostic biomarkers and personalized rehabilitation strategies. While current clinical assessments guide acute management, they often fall short in predicting neurological outcomes and the potential for functional recovery. This study aimed to evaluate the prognostic value of serum nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in the acute phase of IS and to
SUBMITTER: Khodjieva DT
PROVIDER: S-EPMC12514619 | biostudies-literature | 2025 Oct
REPOSITORIES: biostudies-literature